We build FemTech brands that navigate advertising restrictions and cultural sensitivity across the reproductive health journey, from period tracking to fertility to menopause.
The Problem
Meta and Google still throttle reproductive health advertising
Meta's personal-attributes policy and Google's restricted-content rules flag period, fertility, and sexual health terms as sensitive, even for a tracking app, not a medical device. You bid into a smaller inventory pool than general wellness brands, so CPMs run higher for the same audience. Creative gets rejected for words like 'period' that are core to describing your product. VC-backed rivals absorb that tax; bootstrapped brands eat it twice, in cost and reach.
Clinical credibility and warmth pull your voice in opposite directions
Your audience needs medically credible answers but often feels shame raising the topic, so clinical-sounding copy loses the trust that drives conversion, while overly casual copy undercuts the authority the decision requires. A 24-year-old tracking her first cycle and a 40-year-old navigating IVF read the same page and need different reassurance from the same fifty words. Most FemTech brands pick one register and lose the other half of their market.
FTC and FDA scrutiny of health-adjacent claims keeps tightening
Regulators keep sharpening what counts as an implied medical claim from a consumer health app, and that risk sits closer to ordinary marketing copy than most founders assume. You need to sound clinically informed without ever implying you diagnose, treat, or prescribe, and that line moves with the claim, the channel, and the condition you're adjacent to. Getting it wrong risks the trust you spent two years building, not just a takedown.
One brand voice has to serve users at very different life stages
Your product likely serves women managing periods, trying to conceive, avoiding pregnancy, and navigating perimenopause, sometimes in the same subscriber base. A voice tuned for a 25-year-old professional can read as cold to someone on a third IVF cycle, and inclusive language for LGBTQ+ users can clash with how a more traditional segment expects to be described. One message written for all of it lands specifically for none of it.
How We Help
We start with audience research across the reproductive health spectrum, not a single persona: interviews with users from menstrual tracking through fertility to menopause, mapping the language they use for a symptom against the clinical terms they search for. That gap between spoken and search language is where most FemTech copy fails, and closing it makes a brand feel written by someone who gets it.
From there we build platform-specific messaging instead of one script for every channel. Clinical detail lives on your site and in email, where there's no ad-policy filter; social carries community and story, in language that survives Meta and Google review without losing accuracy. Brand guidelines spell out which terms work where, so your team stops guessing every time a campaign gets flagged.
On the regulatory side, we position your brand as a health technology partner, not a treatment provider, building that distinction into the copy itself rather than a bolted-on disclaimer. Working with your legal team, we develop messaging that builds credibility through education, citing what your product tracks and surfaces, without implying diagnosis or cure.
We build the growth strategy and the inclusive-voice framework side by side, because a voice that only works for one demographic caps your addressable market. Then we build the content strategy that carries the brand after we leave: a community where health questions get asked safely, an editorial calendar that teaches instead of sells, and partnerships with providers that extend credibility beyond your own channels.
What we deliver
- Reproductive-health audience research mapping the language gap between spoken symptoms and search terms
- Platform-specific messaging framework built to survive Meta and Google ad review
- Regulatory-aware brand positioning built on education, not implied treatment claims
- Inclusive voice guidelines that flex across age and life stage without going generic
- Community and partnership plan that keeps trust compounding between campaigns
FemTech brands don't earn trust by sounding medical. They earn it by naming a life stage a generic wellness brand won't say out loud, and by staying accurate enough to survive a platform review.
Our Methodology
Our FemTech brand work runs a 90-day, trust-first sequence. Days 1-30 cover audience research across life stages plus a policy audit of which terms and claims are getting current campaigns flagged or throttled. Days 30-60 turn that research into positioning and messaging that holds up for a 25-year-old's cycle-tracking use case and a 40-year-old's fertility journey in the same brand voice. Days 60-90 ship the brand system: guidelines, content templates, and the community structure that keeps trust compounding after the engagement ends. Unlike agency work that writes one voice for everyone, we build backward from the fact that your users are not the same person at every age.
How We Work
The first two to three weeks are research: interviews with current users at different reproductive-health stages, a review of competitor positioning, and an audit of which platform policies are limiting your current advertising. This phase needs time from customer success and a short pull from legal on current claim boundaries.
Days 30-60 run strategy and compliance in parallel. We build positioning and voice guidelines with your marketing team while legal reviews messaging against current FTC and FDA guidance. Content leads get a platform-specific framework so campaigns stop bouncing off ad review, on a weekly working session plus a monthly compliance check-in.
Days 60-90 shift to implementation: guidelines, content templates, and community protocols your team can run without us in the room, plus a lightweight process for tracking platform policy changes. Engagements typically run 3-6 months, with most clients extending into ongoing content and community support once the core system is in place.
- Messaging that clears Meta and Google ad review without losing clinical accuracy
- Brand voice that holds across life stages instead of alienating half your user base
If your femtech company needs brand strategy leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
How much does a brand strategy engagement cost for FemTech companies?
Most FemTech brand strategy engagements run $30,000 to $75,000 for a 90-day build, set by how many audience segments and regulatory touchpoints are in scope. Research spanning multiple life stages and clearance through both platform and FTC review pushes cost above a standard consumer brand build. A single-platform, single-segment scope lands at the lower end. Most clients see engagement and ad-approval movement within 60-90 days.
How long before we see results from a brand strategy engagement?
Ad approval rates and campaign messaging improve within 30-45 days, once the new platform-specific guidelines go live. Community trust metrics move slower, usually 60-90 days, since they depend on your audience seeing and responding to the new voice over time. Full brand maturation across every channel takes 4-6 months, because trust in a health category compounds slowly.
How does the brand strategy team integrate with our existing staff?
We run weekly working sessions with marketing and a monthly compliance check-in with legal, so the work never gets built in isolation from the people who defend it. Your content team gets trained directly on the new framework instead of handed a static deck. Plan on 3-5 hours a week from your team during the active build, dropping once we move into implementation.
What makes Winston Francois different from a traditional brand strategy agency?
Most brand agencies have never had a campaign throttled by Meta's personal-attributes policy or had to write around an FTC claim boundary, so they default to generic wellness language. We build the platform-policy audit and the regulatory read into the brand work itself, not a separate pass at the end. We also refuse to write one voice for every life stage your users are in, because that caps your own market.
How do you measure ROI from brand strategy work?
We track ad approval and rejection rates by platform before and after the new framework ships, since that directly affects CAC. Alongside that we watch community engagement signals like reply rate and organic share, plus content-level trust indicators like save rate and return visits. Platform-approval numbers move first, with community and retention metrics following the next quarter.
What type of FemTech company is the right fit for brand strategy work?
This fits companies with real product-market fit that are losing reach to ad platform restrictions, or losing conversion to a voice that doesn't match how their users talk. It's the wrong engagement for a pre-launch company still validating the product. Companies serving users across multiple reproductive-health stages, not one narrow segment, get the most from the inclusive-voice work.
